Haemonetics
HAE
#3293
Rank
$3.45 B
Marketcap
$68.70
Share price
2.23%
Change (1 day)
-12.33%
Change (1 year)

Operating Margin for Haemonetics (HAE)

Operating Margin as of March 2025 (TTM): 11.60%

According to Haemonetics's latest financial reports and stock price the company's current Operating Margin is 11.60%. At the end of 2024 the company had an Operating Margin of 11.60%.

Operating Margin history for Haemonetics from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202411.60%-4.12%
202312.10%88.86%
20226.41%-23.52%
20218.38%-5%
20208.82%15.86%
20197.61%15.36%
20186.60%-312.76%
2017-3.10%-47.24%
2016-5.88%-271.69%
20153.42%-11.74%
20143.88%-30.66%
20135.59%-54.51%
201212.30%-24.41%
201116.27%29.19%
201012.59%-11.43%
200914.22%-5.02%
200814.97%-6.96%
200716.09%-36.82%
200625.46%63.23%
200515.60%24.03%
200412.58%9.78%
200311.46%-4.79%
200212.03%104.1%
20015.90%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
16.41% 41.47%๐Ÿ‡บ๐Ÿ‡ธ USA
15.45% 33.19%๐Ÿ‡บ๐Ÿ‡ธ USA
9.46%-18.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-11.51%-199.22%๐Ÿ‡บ๐Ÿ‡ธ USA
1.11%-90.43%๐Ÿ‡บ๐Ÿ‡ธ USA
14.13% 21.81%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78% 61.90%๐Ÿ‡บ๐Ÿ‡ธ USA
14.94% 28.79%๐Ÿ‡ฎ๐Ÿ‡ช Ireland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.